REPL

Replimune Group Inc
Health CareUSCUSIP 76029N106◍ Confluence graph
Tracked 13F Holders
189
-79 QoQ
13F Value (tracked)
$676.1M
Insider Net · 180d
-$1.7M
0↑ 6↓
Recent Filings
15
Smart-money sentimentMixed
BearishBullish
13F funds (latest Q)34 adding · 16 trimming
Insider net (180d)-$1.7M

Who owns REPL?

189 tracked 13F filers

189 tracked 13F filers disclose a position in REPL as of the latest SEC 13F filings, a combined $676.1M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

All quarters use one ordinary-share-equivalent series. Historical ADS are converted at 2 ADS = 1 ordinary share. Expand a row for the exact calculation; the residual is not classified as a trade.
#FundPosition valueSharesLast moveAs ofHistory
1BAKER BROS. ADVISORS LP
$84.5M
11.0M
Held
Q1 2026
2PRICE T ROWE ASSOCIATES INC /MD/
$62.1M
8.1M
−1.7%
Reduced · −141K sh
Q1 2026
3RTW INVESTMENTS, LP
$82.0M
7.4M
+0.7%
Added · +55K sh
Q2 2026
4BlackRock, Inc.
$47.7M
6.2M
+2.8%
Added · +170K sh
Q1 2026
5STATE STREET CORP
$49.2M
4.4M
+17%
Added · +658K sh
Q2 2026
6MONTANOVA CAPITAL, LLC
$32.3M
4.2M
117×
Added · +4.2M sh
Q1 2026
7FCPM III SERVICES B.V.
$31.1M
2.8M
Held
Q2 2026
8VANGUARD CAPITAL MANAGEMENT LLC
$21.1M
2.8M
First observed position
No prior filed position
Q1 2026
9D. E. Shaw & Co., Inc.
$17.9M
2.3M
−9.3%
Reduced · −239K sh
Q1 2026
10GOLDMAN SACHS GROUP INC
$17.4M
2.3M
+246%
Added · +1.6M sh
Q1 2026
11Erste Asset Management GmbH
$23.7M
2.1M
Held
Q2 2026
12FMR LLC
$15.6M
2.0M
−31%
Reduced · −936K sh
Q1 2026
13GEODE CAPITAL MANAGEMENT, LLC
$22.5M
2.0M
+13%
Added · +234K sh
Q2 2026
14TORONTO DOMINION BANK
$12.2M
1.6M
−29%
Reduced · −638K sh
Q1 2026
15ADAR1 Capital Management, LLC
$12.1M
1.6M
+28%
Added · +342K sh
Q1 2026
16Boxer Capital Management, LLC
$9.0M
1.2M
+57%
Added · +425K sh
Q1 2026
17DIMENSIONAL FUND ADVISORS LP
$8.7M
1.1M
+1.9%
Added · +21K sh
Q1 2026
18EcoR1 Capital, LLC
$7.7M
1.0M
New
+1.0M sh
Q1 2026
19JPMORGAN CHASE & CO
$5.7M
790K
−15%
Reduced · −135K sh
Q1 2026
20MORGAN STANLEY
$4.9M
646K
−21%
Reduced · −169K sh
Q1 2026
21SUSQUEHANNA INTERNATIONAL GROUP, LLP
$4.8M
624K
+2.8%
Added · +17K sh
Q1 2026
22CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$4.7M
612K
+4.1%
Added · +24K sh
Q1 2026
23Eversept Partners, LP
$6.5M
590K
+76%
Added · +255K sh
Q2 2026
24NORTHERN TRUST CORP
$4.5M
589K
+9.2%
Added · +50K sh
Q1 2026
25UBS Group AG
$4.4M
581K
−3.8%
Reduced · −23K sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is REPL being bought or sold by institutions?

Last quarter, 17 funds opened a new position in REPL and 17 added to an existing one, while 16 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened (NEW)
17
funds
Added
17
funds
Reduced
16
funds
Exited
0
funds

Funds that own REPL also own

CompanyCo-held byCombined value
NVIDIA CORPNVDA99 funds$211.4B
MICROSOFT CORPMSFT98 funds$137.4B
AMAZON.COM INCAMZN98 funds$96.2B
MICRON TECHNOLOGY INCMU97 funds$20.5B
META PLATFORMS INC-CLASS AMETA96 funds$59.5B
ELI LILLY & COLLY96 funds$40.3B
ALPHABET INC-CL AGOOGL93 funds$78.5B
APPLE INCAAPL92 funds$160.7B
BANK OF AMERICA CORPBAC92 funds$14.4B
JPMORGAN CHASE & COJPM91 funds$31.4B
JOHNSON & JOHNSONJNJ91 funds$21.4B
UNITEDHEALTH GROUP INCUNH91 funds$15.7B

Ranked by how many of REPL's institutional holders also hold each name, a cross-fund conviction signal.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$0
0 insiders
Sells · 180d
$1.7M
6 insiders
Net
-$1.7M
13 P/S txns
Signal
Net Selling
open-market
DateInsiderRoleActionSharesValue
Aug 17, 2026Hill Emily LuisaChief Financial OfficerSell (S)9K$132K
Aug 10, 2026Schwendenman AndrewChief Accounting OfficerSell (S)8K$99K
Aug 10, 2026Hill Emily LuisaChief Financial OfficerSell (S)11K$148K
Aug 10, 2026Patel SushilChief Executive Officer, DirectorSell (S)39K$510K
Aug 10, 2026Xynos KonstantinosChief Medical OfficerSell (S)11K$148K
Jun 1, 2026Sarchi ChristopherChief Commercial OfficerSell (S)12K$111K
May 18, 2026Hill Emily LuisaChief Financial OfficerSell (S)8K$40K
May 18, 2026Astley-Sparke PhilipDirectorSell (S)18K$90K
May 18, 2026Patel SushilChief Executive Officer, DirectorSell (S)37K$190K
May 18, 2026Sarchi ChristopherChief Commercial OfficerSell (S)9K$44K
May 18, 2026Schwendenman AndrewChief Accounting OfficerSell (S)8K$40K
May 18, 2026Xynos KonstantinosChief Medical OfficerSell (S)14K$71K

Institutional ownership over time

86 funds-26 since Q3 2024
083165Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
funds holding aggregate valuelatest $236.7M

Recent filings

15 shown

Keep exploring

Connected entities for REPL

Browse more

Build

Ask your agent what changed in REPL

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/REPL/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for REPL.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for REPL. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.